Quasispecies variant of pre-S/S gene in HBV-related hepatocellular carcinoma with HBs antigen positive and occult infection

por Hatazawa, Yuri, Yano, Yoshihiko, Okada, Rina, Tanahashi, Toshihito, Hayashi, Hiroki, Hirano, Hirotaka, Minami, Akihiro, Kawano, Yuki, Tanaka, Motofumi, Fukumoto, Takumi, Murakami, Yoshiki, Yoshida, Masaru, Hayashi, Yoshitake
Publicado 2018

Significance of post‐progression therapy after tyrosine kinase inhibitors for advanced hepatocellular carcinoma

por Yano, Yoshihiko, Yamamoto, Atsushi, Minami, Akihiro, Momose, Kenji, Mimura, Takuya, Kim, Soo Ki, Hayashi, Hiroki, Kado, Takuo, Hirano, Hirotaka, Hirohata, Seiya, Yoon, Seitetsu, Nishi, Katsuhisa, Tei, Hiroshi, Tanaka, Hidenori, Oouchi, Sachiko, Matsuura, Takanori, Yasutomi, Eiichiro, Hatazawa, Yuri, Shiomi, Yuuki, Ueda, Yoshihide, Kodama, Yuzo
Publicado 2022

Factors associated with the response to atezolizumab/bevacizumab combination therapy for hepatocellular carcinoma

por Yano, Yoshihiko, Yamamoto, Atsushi, Mimura, Takuya, Kushida, Saeko, Hirohata, Seiya, Yoon, Seitetsu, Hirano, Hirotaka, Kim, Soo Ki, Hatazawa, Yuri, Momose, Kenji, Hayashi, Hiroki, Kado, Takuo, Nishi, Katsuhisa, Tanaka, Hidenori, Matsuura, Takanori, Yoshida, Ryutaro, Asaji, Naoki, Yasutomi, Eiichiro, Shiomi, Yuuki, Minami, Akihiro, Komatsu, Shohei, Fukumoto, Takumi, Ueda, Yoshihide, Kodama, Yuzo
Publicado 2023